• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

4
1
1
1

COUNTRY

1

CATEGORIES

  • 33
  • 11
  • 5
  • 4
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

6
6
48
53

PUBLISHED

1
11
46
53

PRODUCT TYPE

47
6

Search "Cubist Pharmaceuticals Inc.-Therapeutic Competitors" returned 53 results.

PRODUCT TITLE

Cubist Pharmaceuticals, Inc. (CBST) - Financial and Strategic SWOT Analysis Review

Cubist Pharmaceuticals, Inc. (CBST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

April 2014
FROM

Cubist Pharmaceuticals Incorporated

A textual analysis of the financial results for Cubist Pharmaceuticals Incorporated compared to selected competitors. Also included are quantitative analyses of the company's financial statements,...

December 2014

Achillion Pharmaceuticals, Inc. (ACHN) - Financial and Strategic SWOT Analysis Review

Achillion Pharmaceuticals, Inc. (ACHN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been...

April 2014
FROM

United Therapeutics Corporation

A textual analysis of the financial results for United Therapeutics Corporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive...

January 2015
Alnylam Pharmaceuticals, Inc (ALNY) - Financial and Strategic SWOT Analysis Review Alnylam Pharmaceuticals, Inc (ALNY) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Alnylam Pharmaceuticals, Inc (ALNY) - Financial and Strategic SWOT Analysis Review

Alnylam Pharmaceuticals, Inc (ALNY) - Financial and Strategic SWOT Analysis Review Summary Alnylam Pharmaceuticals, Inc., (Alnylam) is a biopharmaceutical company focusing on the discovery, development...

April 2012
FROM

Complicated Intra-Abdominal Infections - Pipeline Review, H2 2014

Complicated Intra-Abdominal Infections - Pipeline Review, H2 2014 Summary This, ‘Complicated Intra-Abdominal Infections - Pipeline Review, H2 2014’, provides an overview of the Complicated Intra-Abdominal...

August 2014
FROM

Complicated Intra-Abdominal Infections - Pipeline Review, H1 2014

Complicated Intra-Abdominal Infections - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Complicated Intra-Abdominal Infections - Pipeline Review, H1 2014’, provides an overview of the...

March 2014
FROM
Skin And Soft Tissue Infections - Pipeline Review, H2 2014 Skin And Soft Tissue Infections - Pipeline Review, H2 2014 - Product Thumbnail Image

Skin And Soft Tissue Infections - Pipeline Review, H2 2014

Skin And Soft Tissue Infections - Pipeline Review, H2 2014 Summary This, ‘Skin And Soft Tissue Infections - Pipeline Review, H2 2014’, provides an overview of the Skin And Soft Tissue Infections’s...

November 2014
FROM

Pyelonephritis - Pipeline Review, H1 2014

Pyelonephritis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Pyelonephritis - Pipeline Review, H1 2014’, provides an overview of the Pyelonephritis’s therapeutic pipeline. This report...

May 2014
FROM
Pyelonephritis - Pipeline Review, H2 2014 Pyelonephritis - Pipeline Review, H2 2014 - Product Thumbnail Image

Pyelonephritis - Pipeline Review, H2 2014

Pyelonephritis - Pipeline Review, H2 2014 Summary This, ‘Pyelonephritis - Pipeline Review, H2 2014’, provides an overview of the Pyelonephritis’s therapeutic pipeline. This report provides comprehensive...

November 2014
FROM

Ventilator Associated Pneumonia (VAP) - Pipeline Review, H1 2014

Ventilator Associated Pneumonia (VAP) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Ventilator Associated Pneumonia (VAP) - Pipeline Review, H1 2014’, provides an overview of the Ventilator...

February 2014
FROM

Hospital Acquired Pneumonia (HAP) - Pipeline Review, H1 2014

Hospital Acquired Pneumonia (HAP) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Hospital Acquired Pneumonia (HAP) - Pipeline Review, H1 2014’, provides an overview of the Hospital Acquired...

June 2014
FROM
Hospital Acquired Pneumonia (HAP) - Pipeline Review, H2 2014 Hospital Acquired Pneumonia (HAP) - Pipeline Review, H2 2014 - Product Thumbnail Image

Hospital Acquired Pneumonia (HAP) - Pipeline Review, H2 2014

Hospital Acquired Pneumonia (HAP) - Pipeline Review, H2 2014 Summary This, ‘Hospital Acquired Pneumonia (HAP) - Pipeline Review, H2 2014’, provides an overview of the Hospital Acquired Pneumonia (HAP)’s...

December 2014
FROM

Ventilator Associated Pneumonia (VAP) - Pipeline Review, H2 2014

Ventilator Associated Pneumonia (VAP) - Pipeline Review, H2 2014 Summary This, ‘Ventilator Associated Pneumonia (VAP) - Pipeline Review, H2 2014’, provides an overview of the Ventilator Associated...

July 2014
FROM

Urinary Tract Infections - Pipeline Review, H1 2014

Urinary Tract Infections - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Urinary Tract Infections - Pipeline Review, H1 2014’, provides an overview of the Urinary Tract Infections’s therapeutic...

March 2014
FROM

Gonorrhea - Pipeline Review, H2 2014

Gonorrhea - Pipeline Review, H2 2014 Summary This, ‘Gonorrhea - Pipeline Review, H2 2014’, provides an overview of the Gonorrhea’s therapeutic pipeline. This report provides comprehensive information...

October 2014
FROM

Cystic Fibrosis - Pipeline Review, H2 2014

Cystic Fibrosis - Pipeline Review, H2 2014 Summary This, ‘Cystic Fibrosis - Pipeline Review, H2 2014’, provides an overview of the Cystic Fibrosis’s therapeutic pipeline. This report provides comprehensive...

October 2014
FROM

Accentia Biopharmaceuticals, Inc. (ABPI) - Financial and Strategic SWOT Analysis Review

Summary Accentia Biopharmaceuticals, Inc. (Accentia) is a biotechnology company. It identifies, develops and commercializes patent-protected disruptive healthcare technologies for the treatment of...

January 2013
FROM

Cystic Fibrosis - Pipeline Review, H1 2014

Cystic Fibrosis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Cystic Fibrosis - Pipeline Review, H1 2014’, provides an overview of the Cystic Fibrosis’s therapeutic pipeline. This...

April 2014
FROM

Community-Acquired Bacterial Pneumonia - Pipeline Review, H1 2014

Community-Acquired Bacterial Pneumonia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Community-Acquired Bacterial Pneumonia - Pipeline Review, H1 2014’, provides an overview of the...

May 2014
FROM
Loading Indicator

Our Clients

Glanbia Plc. Unilever N.V. Microsoft Corporation Duke University A.T. Kearney PepsiCo Inc. Boston Consulting Group